-
Presentation
Presentation
The creation of technology-based companies has very specific features that justify teaching for future biochemical professionals who want to move into a bio-entrepreneurial career. The knowledge to transmit starts with the differences between a start-up and a spin-off company in the area of biotechnology. Moreover, the course will teach the differences and complementarities between biotech companies and the pharmaceutical industry (big pharma, biopharma).
-
Class from course
Class from course
-
Degree | Semesters | ECTS
Degree | Semesters | ECTS
Bachelor | Semestral | 5
-
Year | Nature | Language
Year | Nature | Language
3 | Mandatory | Português
-
Code
Code
ULHT2710-17411
-
Prerequisites and corequisites
Prerequisites and corequisites
Not applicable
-
Professional Internship
Professional Internship
Não
-
Syllabus
Syllabus
- Characterization of spin-off companies.
- Examples of start-ups and spin-offs in red biotech
- Examples of start-ups and spin-offs in green biotech
- Examples of start-ups and spin-offs in blue biotech
- Examples of start-ups and spin-offs in white biotech
- The importance of analysis of the freedom to operate (FTO) in the creation and consolidation of start-up and spin-off companies, and of the IP (intellectual property) of the main technologies used to launch the new company.
- Analysis of competitors and benchmark in the process of setting up a start-up or spin-off businesses.
- Introduction to the development of a business plan and a marketing plan for the launch of new companies or new products and for new services in consolidated companies.
- Structuring licensing agreements between pharma & biotech, covering the typical cases for payment by milestones and by royalties.
-
Objectives
Objectives
The creation of technology-based companies has very specific features that justify teaching for future biochemical professionals who want to move into a bio-entrepreneurial career. The knowledge to transmit starts with the differences between a start-up and a spin-off company in the area of biotechnology. Moreover, the course will teach the differences and complementarities between biotech companies and the pharmaceutical industry (big pharma, biopharma). It is intended that the students gain the ability to distinguish between companies of the "red biotech", "blue biotech," "green biotech" and "white biotech". In the end, the objective is that students develop skills to create or participate in the creation, from scratch, of a new biotech company and to analyze in detail the issues related to their "freedom to operate". Students should also be able to make the assessment of the value of a biotech company or pharma company, both consolidated or in its consolidation path.
-
Teaching methodologies and assessment
Teaching methodologies and assessment
A business plan will be prepared throughout the classes. A pitch will be prepared and will be presented in the current model of presentation to investors. This work will be presented to the class
-
References
References
- Scientific papers related to the subject
-
Office Hours
Office Hours
-
Mobility
Mobility
No